Farnesyltransferase: Theoretical studies on peptide substrate entrance—thiol or thiolate coordination?

Abstract During the last decade, farnesyltransferase enzyme (FTase) has established itself as a very promising target in anticancer research, with more than 100 patents describing farnesyltransferase inhibitors (FTIs) published since 2000. However, several crucial doubts in its catalytic mechanism still remain. Understanding the farnesylation mechanism of the natural substrates of FTase would allow the development of more specific and active inhibitors of this enzyme. One of the fundamental dilemmas which characterize the FTase mechanism is the coordination of the peptide substrate. It is known that peptide coordination results in the formation of a zinc thiolate; however, the exact protonation state of the peptide cysteine that reacts with zinc–thiol or thiolate-remains unknown. In this study, the potential energy surfaces for thiol and thiolate peptides entrance into the active-site zinc coordination sphere were determined. The results show that the Gibbs activation barrier for thiolate entrance is of around 20 kcal/mol, whereas for thiol entrance is of only 2.5 kcal/mol. Globally, the results demonstrate that the substrate peptide coordinates zinc as a thiol, subsequently losing a proton to give the thiolate bound minimum, and that a direct thiolate attack is not a kinetically competitive alternative.

[1]  Michael Dolg,et al.  Energy‐adjusted ab initio pseudopotentials for the first row transition elements , 1987 .

[2]  Charles W. Bauschlicher,et al.  A comparison of the accuracy of different functionals , 1995 .

[3]  C. Farnsworth,et al.  Role of protein modification reactions in programming interactions between ras-related GTPases and cell membranes. , 1994, Annual review of cell biology.

[4]  P. Casey,et al.  High level expression of mammalian protein farnesyltransferase in a baculovirus system. The purified protein contains zinc. , 1993, The Journal of biological chemistry.

[5]  J. Shafer,et al.  Isoprenoid diphosphate utilization by recombinant human farnesyl:protein transferase: interactive binding between substrates and a preferred kinetic pathway. , 1993, Biochemistry.

[6]  Mayuso Kuno,et al.  Theoretical investigation on nevirapine and HIV-1 reverse transcriptase binding site interaction, based on ONIOM method , 2003 .

[7]  P. Casey,et al.  H-Ras peptide and protein substrates bind protein farnesyltransferase as an ionized thiolate. , 1998, Biochemistry.

[8]  W. Schafer,et al.  Protein prenylation: genes, enzymes, targets, and functions. , 1992, Annual review of genetics.

[9]  K. Morokuma,et al.  On the application of the IMOMO (integrated molecular orbital + molecular orbital) method , 2000 .

[10]  J. Stewart.  Optimization of parameters for semiempirical methods I. Method , 1989 .

[11]  J. Stewart.  Optimization of parameters for semiempirical methods. III Extension of PM3 to Be, Mg, Zn, Ga, Ge, As, Se, Cd, In, Sn, Sb, Te, Hg, Tl, Pb, and Bi , 1991 .

[12]  G. Klebe,et al.  Farnesyltransferase inhibitors inhibit the growth of malaria parasites in vitro and in vivo. , 2004, Angewandte Chemie.

[13]  J. Stewart.  Optimization of parameters for semiempirical methods II. Applications , 1989 .

[14]  Ping Liu,et al.  In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus. , 2003, The Journal of clinical investigation.

[15]  K. Morokuma,et al.  A NEW ONIOM IMPLEMENTATION IN GAUSSIAN98. PART I. THE CALCULATION OF ENERGIES, GRADIENTS, VIBRATIONAL FREQUENCIES AND ELECTRIC FIELD DERIVATIVES , 1999 .

[16]  D. Chakrabarti,et al.  Protein Farnesyltransferase and Protein Prenylation inPlasmodium falciparum * , 2002, The Journal of Biological Chemistry.

[17]  S. Rodenhuis.  ras and human tumors. , 1992, Seminars in cancer biology.

[18]  C. Poulter,et al.  A mechanism for posttranslational modifications of proteins by yeast protein farnesyltransferase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Marshall,et al.  All ras proteins are polyisoprenylated but only some are palmitoylated , 1989, Cell.

[20]  S. Croft,et al.  Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agents. , 2004, Journal of medicinal chemistry.

[21]  Pedro Alexandrino Fernandes,et al.  Theoretical studies on the mechanism of inhibition of Ribonucleotide Reductase by (E)-2'-Fluoromethylene-2'-deoxycitidine-5'-diphosphate. , 2003, Journal of the American Chemical Society.

[22]  S. Moores,et al.  Sequence dependence of protein isoprenylation. , 1991, The Journal of biological chemistry.

[23]  P. Casey,et al.  The basis for K-Ras4B binding specificity to protein farnesyltransferase revealed by 2 A resolution ternary complex structures. , 2000, Structure.

[24]  H. Stoll,et al.  Energy-adjustedab initio pseudopotentials for the second and third row transition elements , 1990 .

[25]  Per E M Siegbahn,et al.  Catalytic mechanism of matrix metalloproteinases: two-layered ONIOM study. , 2002, Inorganic chemistry.

[26]  Chia‐Yu Huang,et al.  Farnesyltransferase inhibitors: recent advances , 2004 .

[27]  M. Bräuer,et al.  Evaluation of the accuracy of PM3, AM1 and MNDO/d as applied to zinc compounds , 2000 .

[28]  A. Becke.  Density-functional thermochemistry. III. The role of exact exchange , 1993 .

[29]  P. Casey,et al.  Protein farnesyltransferase: kinetics of farnesyl pyrophosphate binding and product release. , 1995, Biochemistry.

[30]  Pedro Alexandrino Fernandes,et al.  Theoretical studies on the mode of inhibition of ribonucleotide reductase by 2'-substituted substrate analogues. , 2003, Chemistry.

[31]  Wolfram Koch,et al.  The performance of density functional/Hartree-Fock hybrid methods: the bonding in cationic first-row transition metal methylene complexes , 1995 .

[32]  R. M. Izatt,et al.  Thermodynamics of Proton Dissociation in Aqueous Solution. III. L-Cysteine, S-Methyl-L-cysteine, and Mercaptoacetic Acid. Determination of Cysteine Microconstants from Calorimetric Data , 1964 .

[33]  Maria João Ramos,et al.  Farnesyltransferase--new insights into the zinc-coordination sphere paradigm: evidence for a carboxylate-shift mechanism. , 2005, Biophysical journal.

[34]  C. Der,et al.  Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Y. Reiss,et al.  Divalent cation and prenyl pyrophosphate specificities of the protein farnesyltransferase from rat brain, a zinc metalloenzyme. , 1992, The Journal of biological chemistry.

[36]  S. Sebti,et al.  Inhibitors of protein farnesyltransferase as novel anticancer agents. , 2002, Current Topics in Medicinal Chemistry.

[37]  Thom Vreven,et al.  Model studies of the structures, reacitivities, and reaction mechanisms of metalloenzymes , 2001, IBM J. Res. Dev..

[38]  U. Ryde,et al.  Carboxylate binding modes in zinc proteins: a theoretical study. , 1999, Biophysical journal.

[39]  P. Fernandes,et al.  Theoretical insights into the mechanism for thiol/disulfide exchange. , 2004, Chemistry.

[40]  K. Morokuma,et al.  Effects of the protein environment on the structure and energetics of active sites of metalloenzymes. ONIOM study of methane monooxygenase and ribonucleotide reductase. , 2002, Journal of the American Chemical Society.

[41]  C. Der,et al.  Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  T. Ziegler.  Approximate Density Functional Theory as a Practical Tool in Molecular Energetics and Dynamics , 1991 .

[43]  P. Casey,et al.  Protein prenylation: molecular mechanisms and functional consequences. , 1996, Annual review of biochemistry.

[44]  Parr,et al.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. , 1988, Physical review. B, Condensed matter.

[45]  C. Fierke,et al.  Role of metals in the reaction catalyzed by protein farnesyltransferase. , 2000, Biochemistry.